BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 8761432)

  • 21. 3'-Hydroxypterostilbene Inhibits 7,12-Dimethylbenz[a]anthracene (DMBA)/12-O-Tetradecanoylphorbol-13-Acetate (TPA)-Induced Mouse Skin Carcinogenesis.
    Lee PS; Chiou YS; Chou PY; Nagabhushanam K; Ho CT; Pan MH
    Phytomedicine; 2021 Jan; 81():153432. PubMed ID: 33310310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA adducts, cell proliferation and papilloma latency time in mouse skin after repeated dermal application of DMBA and TPA.
    Fischer WH; Beland PE; Lutz WK
    Carcinogenesis; 1993 Jul; 14(7):1285-8. PubMed ID: 8330341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen.
    Binder RL; Johnson GR; Gallagher PM; Stockman SL; Sundberg JP; Conti CJ
    Cancer Res; 1998 Oct; 58(19):4314-23. PubMed ID: 9766659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effect of Ocimum sanctum on 3-methylcholanthrene, 7,12-dimethylbenz(a)anthracene and aflatoxin B1 induced skin tumorigenesis in mice.
    Rastogi S; Shukla Y; Paul BN; Chowdhuri DK; Khanna SK; Das M
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):228-40. PubMed ID: 17669454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of combined phytochemicals on skin tumorigenesis in SENCAR mice.
    Kowalczyk MC; Junco JJ; Kowalczyk P; Tolstykh O; Hanausek M; Slaga TJ; Walaszek Z
    Int J Oncol; 2013 Sep; 43(3):911-8. PubMed ID: 23835587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin.
    Hsieh YH; Juliana MM; Hicks PH; Feng G; Elmets C; Liaw L; Chang PL
    Cancer Res; 2006 Jul; 66(14):7119-27. PubMed ID: 16849558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin.
    Hennings H; Glick AB; Lowry DT; Krsmanovic LS; Sly LM; Yuspa SH
    Carcinogenesis; 1993 Nov; 14(11):2353-8. PubMed ID: 8242866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential inhibition by staurosporine, a potent protein kinase C inhibitor, of 12-O-tetradecanoylphorbol-13-acetate-caused skin tumor promotion, epidermal ornithine decarboxylase induction, hyperplasia and inflammation.
    Yamamoto S; Kiyoto I; Aizu E; Nakadate T; Hosoda Y; Kato R
    Carcinogenesis; 1989 Jul; 10(7):1315-22. PubMed ID: 2544313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor-alpha-induced epidermal growth factor receptor activation but not p53 inactivation.
    Shibata MA; Ward JM; Green JE; Merlino G
    Mol Carcinog; 1997 Mar; 18(3):160-70. PubMed ID: 9115586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein kinase Cepsilon is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-alpha ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase Cepsilon transgenic mice.
    Wheeler DL; Ness KJ; Oberley TD; Verma AK
    Cancer Res; 2003 Oct; 63(19):6547-55. PubMed ID: 14559850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapamycin is a potent inhibitor of skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
    Checkley LA; Rho O; Moore T; Hursting S; DiGiovanni J
    Cancer Prev Res (Phila); 2011 Jul; 4(7):1011-20. PubMed ID: 21733825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-1alpha up-regulation in vivo by a potent carcinogen 7,12-dimethylbenz(a)anthracene (DMBA) and control of DMBA-induced inflammatory responses.
    Li X; Eckard J; Shah R; Malluck C; Frenkel K
    Cancer Res; 2002 Jan; 62(2):417-23. PubMed ID: 11809690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of interleukin-1 alpha mRNA expression in mouse epidermis by tumor promoters and antagonists.
    Lee WY; Fischer SM; Butler AP; Locniskar MF
    Mol Carcinog; 1993; 7(1):26-35. PubMed ID: 8435107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of effect of retinoic acid and fluocinolone acetonide on mirex tumor promotion indicates a novel mirex mechanism.
    Kim TW; Smart RC
    Carcinogenesis; 1995 Sep; 16(9):2199-204. PubMed ID: 7554075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype.
    Kim TW; Porter KL; Foley JF; Maronpot RR; Smart RC
    Mol Carcinog; 1997 Sep; 20(1):115-24. PubMed ID: 9328442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin.
    Ridd K; Zhang SD; Edwards RE; Davies R; Greaves P; Wolfreys A; Smith AG; Gant TW
    Carcinogenesis; 2006 Aug; 27(8):1556-66. PubMed ID: 16537558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
    La E; Muga SJ; Locniskar MF; Fischer SM
    Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
    Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
    Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metallothionein deficiency enhances skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate in metallothionein-null mice.
    Suzuki JS; Nishimura N; Zhang B; Nakatsuru Y; Kobayashi S; Satoh M; Tohyama C
    Carcinogenesis; 2003 Jun; 24(6):1123-32. PubMed ID: 12807749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin E is a complete tumor promoter in mouse skin.
    Mitchel RE; McCann R
    Carcinogenesis; 1993 Apr; 14(4):659-62. PubMed ID: 8472330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.